Submitted by Anonymous (not verified) on 17 September 2025 - 15:30
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 13, Status: Authorised